BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Doxorubicin
,
rs2476601
,
SIRT1
,
nitric oxide metabolic process
,
Ischemia
,
Retina
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
CD40-ligand
Summary
General Info
Curated Studies
Most Correlated Studies
Early changes in gene expression in antigen receptor activated B cells
B cell differentiation series through plasmablast stage to antibody secreting plasma cell
Blasts, pre-plasma blasts, and B cells from Prdm1-GFP knockin null mice
B cells from autosomal dominant hyper IgE syndrome patients cultured with CD40L and IL21
Memory B cells sorted for FCRL4+/- cell fractions after activation with sCD40L or CpG ODN 2006
Explore Curated Studies Results
Literature
Most Relevant Literature
CD40L Activates Platelet Integrin αIIbβ3 by Binding to the Allosteric Site (Site 2) in a KGD-Indepen…
CD40 Ligand Deficiency in Latin America: Clinical, Immunological, and Genetic Characteristics.
3-hydroxy butyrate dehydrogenase 2 deficiency aggravates systemic lupus erythematosus progression in…
Dual intracellular staining of CD154 (CD40L) and cytokines at single-cell level: A novel aid to docu…
Novel Functions of Integrins as Receptors of CD154: Their Role in Inflammation and Apoptosis.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
CD40 Ligand Expressing MSLN-CAR T Cell Therapy in MSLN Positive Advanced/Metastatic Solid Tumors
FLT3 Ligand, CD40 Agonist Antibody, and Stereotactic Radiotherapy
Treating High Risk Leukemia With CD40 Ligand & IL-2 Gene Modified Tumor Vaccine
Study of Immune Responses and Safety of Recombinant Human CD40 Ligand in Patients With X-Linked Hype…
Safety Study on the Transfer of the CD40 Ligand Gene (AdcuCD40L) to Patients With Esophageal Carcino…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ